SEC Form 4 · accession 0001144204-16-100562
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen P. Carey
Officer — Vice President and CFO
Period of report
May 6, 2016
Accepted (ET)
May 10, 2016 · 5:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to PurchaseF1 | $46.49 | May 6, 2016 | A | 50,000 | A | May 6, 2017 | May 5, 2026 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The options vest in an equal annual amount over a four-year period beginning on the first anniversary of the grant date.